Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Michalski

Showing results (231-240 of 259) with videos related to

Pageof 26
Sort By:
Gut|January 21, 2015
A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signallingBo Kong, Weiwei Wu, Tao Cheng, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 28, 2018
Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal AdenocarcinomaZiying Jian, Tao Cheng, Zhiheng Zhang, et al.
BMJ Open|June 27, 2025
Selective neoadjuvant therapy of rectal cancer patients (SELREC): study protocol for a European randomised controlled, open, multicentre non-inferiority trialRosa Klotz, Cosima Engerer, Solveig Tenckhoff, et al.
Cancer Cell|March 5, 2013
Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancerStefan Eser, Nina Reiff, Marlena Messer, et al.
The Journal of Pathology|February 5, 2025
Unveiling the intriguing relationship: oncogenic KRAS, morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasmsLucas-Alexander Schulte, Annika Beck, Ralf Marienfeld, et al.
Gut|September 21, 2016
Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancyBo Kong, Philipp Bruns, Nora A Behler, et al.
BMJ Open|September 11, 2025
Heidelberg Perioperative Deep Data Study (HeiPoDD): study protocol for a prospective cohort study for prediction of complications after high-risk non-cardiac surgery in a German university hospitalMona Jung-König, Hans Thomas Hölzer, Solveig Tenckhoff, et al.
Gastroenterology|July 25, 2021
AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53Zhiheng Zhang, Hongzhen Li, Yibin Deng, et al.
Journal of the National Cancer Institute|December 1, 2025
NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancerDylan Williams, Chandni Patel, Kate Murray, et al.
Gut|November 26, 2011
StellaTUM: current consensus and discussion on pancreatic stellate cell researchMert Erkan, Guido Adler, Minoti V Apte, et al.
Pageof 26

Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Gut|January 21, 2015
A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signallingBo Kong, Weiwei Wu, Tao Cheng, et al.
Cellular and Molecular Gastroenterology and Hepatology|September 28, 2018
Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal AdenocarcinomaZiying Jian, Tao Cheng, Zhiheng Zhang, et al.
BMJ Open|June 27, 2025
Selective neoadjuvant therapy of rectal cancer patients (SELREC): study protocol for a European randomised controlled, open, multicentre non-inferiority trialRosa Klotz, Cosima Engerer, Solveig Tenckhoff, et al.
Cancer Cell|March 5, 2013
Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancerStefan Eser, Nina Reiff, Marlena Messer, et al.
The Journal of Pathology|February 5, 2025
Unveiling the intriguing relationship: oncogenic KRAS, morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasmsLucas-Alexander Schulte, Annika Beck, Ralf Marienfeld, et al.
Gut|September 21, 2016
Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancyBo Kong, Philipp Bruns, Nora A Behler, et al.
BMJ Open|September 11, 2025
Heidelberg Perioperative Deep Data Study (HeiPoDD): study protocol for a prospective cohort study for prediction of complications after high-risk non-cardiac surgery in a German university hospitalMona Jung-König, Hans Thomas Hölzer, Solveig Tenckhoff, et al.
Gastroenterology|July 25, 2021
AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53Zhiheng Zhang, Hongzhen Li, Yibin Deng, et al.
Journal of the National Cancer Institute|December 1, 2025
NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancerDylan Williams, Chandni Patel, Kate Murray, et al.
Gut|November 26, 2011
StellaTUM: current consensus and discussion on pancreatic stellate cell researchMert Erkan, Guido Adler, Minoti V Apte, et al.
Pageof 26